Combination of an agent that attenuates topoisomerase 1...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 45/06 (2006.01) A61K 31/365 (2006.01) A61K 31/47 (2006.01) A61K 31/7028 (2006.01) A61K 31/706 (2006.01) A61P 31/00 (2006.01) A61P 33/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2482593

The present invention relates to the use of a first agent that attenuates Topoisomerase I (Topo I) activity and a second agent that inhibits Heat Shock Protein 90 (HSP90) for use in chemotherapy. The agents are particularly useful in the treatment of cancer and destruction of micro-organisms. The invention also relates to screening methods, diagnostic methods and methods for evaluating or monitoring chemotherapy regimens.

L'invention concerne l'utilisation d'un premier agent qui atténue l'activité de la topoisomérase I (Topo I) et d'un second agent qui inhibe la protéine du choc thermique 90 (HSP90), à utiliser en chimiothérapie. Ces agents sont particulièrement utiles dans le traitement du cancer et dans la destruction de micro-organismes. L'invention concerne également des méthodes de criblage, des méthodes diagnostiques ainsi que des méthodes d'évaluation ou de contrôle de régimes de chimiothérapie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination of an agent that attenuates topoisomerase 1... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of an agent that attenuates topoisomerase 1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of an agent that attenuates topoisomerase 1... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1644782

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.